 | • レポートコード：MRC2-11QY04109 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は起立性低血圧のグローバル市場について調査・分析したレポートです。種類別（心電図、血液検査、ストレステスト、心エコー図）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別起立性低血圧の競争状況、市場シェア ・世界の起立性低血圧市場：種類別市場規模 2015年-2020年（心電図、血液検査、ストレステスト、心エコー図） ・世界の起立性低血圧市場：種類別市場規模予測 2021年-2026年（心電図、血液検査、ストレステスト、心エコー図） ・世界の起立性低血圧市場：用途別市場規模 2015年-2020年（病院、クリニック、外来外科センター） ・世界の起立性低血圧市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来外科センター） ・北米の起立性低血圧市場分析：米国、カナダ ・ヨーロッパの起立性低血圧市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの起立性低血圧市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の起立性低血圧市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの起立性低血圧市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Mylan、Roche、Upsher-Smith Laboratories、Chelsea Therapeutics、Amgen、Apotex ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine problems and nervous system disorders.
The orthostatic hypotension disorder is mostly common in the elderly, teenagers and postpartum mothers. The key drivers that can boost the orthostatic hypotension market are increasing in the aging population with increase in the prevalence of diabetes and heart disorders along with availability of increasing number of treatments options. Increasing adoption and integration of technologies in healthcare premises along with emergence of new entrants in the existing market is expected to further propel the demand for treatment of orthostatic hypotension worldwide.
Market Analysis and Insights: Global Orthostatic Hypotension Market
The global Orthostatic Hypotension market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Orthostatic Hypotension Scope and Market Size
Orthostatic Hypotension market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orthostatic Hypotension market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Mylan
Roche
Upsher-Smith Laboratories
Chelsea Therapeutics
Amgen
Apotex
…
Market segment by Type, the product can be split into
ECG
Blood Tests
Stress Test
Echocardiogram
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orthostatic Hypotension Revenue
1.4 Market by Type
1.4.1 Global Orthostatic Hypotension Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ECG
1.4.3 Blood Tests
1.4.4 Stress Test
1.4.5 Echocardiogram
1.5 Market by Application
1.5.1 Global Orthostatic Hypotension Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Orthostatic Hypotension Market Perspective (2015-2026)
2.2 Global Orthostatic Hypotension Growth Trends by Regions
2.2.1 Orthostatic Hypotension Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Orthostatic Hypotension Historic Market Share by Regions (2015-2020)
2.2.3 Orthostatic Hypotension Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Orthostatic Hypotension Market Growth Strategy
2.3.6 Primary Interviews with Key Orthostatic Hypotension Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Orthostatic Hypotension Players by Market Size
3.1.1 Global Top Orthostatic Hypotension Players by Revenue (2015-2020)
3.1.2 Global Orthostatic Hypotension Revenue Market Share by Players (2015-2020)
3.1.3 Global Orthostatic Hypotension Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Orthostatic Hypotension Market Concentration Ratio
3.2.1 Global Orthostatic Hypotension Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Orthostatic Hypotension Revenue in 2019
3.3 Orthostatic Hypotension Key Players Head office and Area Served
3.4 Key Players Orthostatic Hypotension Product Solution and Service
3.5 Date of Enter into Orthostatic Hypotension Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Orthostatic Hypotension Historic Market Size by Type (2015-2020)
4.2 Global Orthostatic Hypotension Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Orthostatic Hypotension Market Size by Application (2015-2020)
5.2 Global Orthostatic Hypotension Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Orthostatic Hypotension Market Size (2015-2020)
6.2 Orthostatic Hypotension Key Players in North America (2019-2020)
6.3 North America Orthostatic Hypotension Market Size by Type (2015-2020)
6.4 North America Orthostatic Hypotension Market Size by Application (2015-2020)
7 Europe
7.1 Europe Orthostatic Hypotension Market Size (2015-2020)
7.2 Orthostatic Hypotension Key Players in Europe (2019-2020)
7.3 Europe Orthostatic Hypotension Market Size by Type (2015-2020)
7.4 Europe Orthostatic Hypotension Market Size by Application (2015-2020)
8 China
8.1 China Orthostatic Hypotension Market Size (2015-2020)
8.2 Orthostatic Hypotension Key Players in China (2019-2020)
8.3 China Orthostatic Hypotension Market Size by Type (2015-2020)
8.4 China Orthostatic Hypotension Market Size by Application (2015-2020)
9 Japan
9.1 Japan Orthostatic Hypotension Market Size (2015-2020)
9.2 Orthostatic Hypotension Key Players in Japan (2019-2020)
9.3 Japan Orthostatic Hypotension Market Size by Type (2015-2020)
9.4 Japan Orthostatic Hypotension Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Orthostatic Hypotension Market Size (2015-2020)
10.2 Orthostatic Hypotension Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Orthostatic Hypotension Market Size by Type (2015-2020)
10.4 Southeast Asia Orthostatic Hypotension Market Size by Application (2015-2020)
11 India
11.1 India Orthostatic Hypotension Market Size (2015-2020)
11.2 Orthostatic Hypotension Key Players in India (2019-2020)
11.3 India Orthostatic Hypotension Market Size by Type (2015-2020)
11.4 India Orthostatic Hypotension Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Orthostatic Hypotension Market Size (2015-2020)
12.2 Orthostatic Hypotension Key Players in Central & South America (2019-2020)
12.3 Central & South America Orthostatic Hypotension Market Size by Type (2015-2020)
12.4 Central & South America Orthostatic Hypotension Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Mylan
13.1.1 Mylan Company Details
13.1.2 Mylan Business Overview
13.1.3 Mylan Orthostatic Hypotension Introduction
13.1.4 Mylan Revenue in Orthostatic Hypotension Business (2015-2020))
13.1.5 Mylan Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Orthostatic Hypotension Introduction
13.2.4 Roche Revenue in Orthostatic Hypotension Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Upsher-Smith Laboratories
13.3.1 Upsher-Smith Laboratories Company Details
13.3.2 Upsher-Smith Laboratories Business Overview
13.3.3 Upsher-Smith Laboratories Orthostatic Hypotension Introduction
13.3.4 Upsher-Smith Laboratories Revenue in Orthostatic Hypotension Business (2015-2020)
13.3.5 Upsher-Smith Laboratories Recent Development
13.4 Chelsea Therapeutics
13.4.1 Chelsea Therapeutics Company Details
13.4.2 Chelsea Therapeutics Business Overview
13.4.3 Chelsea Therapeutics Orthostatic Hypotension Introduction
13.4.4 Chelsea Therapeutics Revenue in Orthostatic Hypotension Business (2015-2020)
13.4.5 Chelsea Therapeutics Recent Development
13.5 Amgen
13.5.1 Amgen Company Details
13.5.2 Amgen Business Overview
13.5.3 Amgen Orthostatic Hypotension Introduction
13.5.4 Amgen Revenue in Orthostatic Hypotension Business (2015-2020)
13.5.5 Amgen Recent Development
13.6 Apotex
13.6.1 Apotex Company Details
13.6.2 Apotex Business Overview
13.6.3 Apotex Orthostatic Hypotension Introduction
13.6.4 Apotex Revenue in Orthostatic Hypotension Business (2015-2020)
13.6.5 Apotex Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Orthostatic Hypotension Key Market Segments
Table 2. Key Players Covered: Ranking by Orthostatic Hypotension Revenue
Table 3. Ranking of Global Top Orthostatic Hypotension Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Orthostatic Hypotension Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ECG
Table 6. Key Players of Blood Tests
Table 7. Key Players of Stress Test
Table 8. Key Players of Echocardiogram
Table 9. Global Orthostatic Hypotension Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Orthostatic Hypotension Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Orthostatic Hypotension Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Orthostatic Hypotension Market Share by Regions (2015-2020)
Table 13. Global Orthostatic Hypotension Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Orthostatic Hypotension Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Orthostatic Hypotension Market Growth Strategy
Table 19. Main Points Interviewed from Key Orthostatic Hypotension Players
Table 20. Global Orthostatic Hypotension Revenue by Players (2015-2020) (Million US$)
Table 21. Global Orthostatic Hypotension Market Share by Players (2015-2020)
Table 22. Global Top Orthostatic Hypotension Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthostatic Hypotension as of 2019)
Table 23. Global Orthostatic Hypotension by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Orthostatic Hypotension Product Solution and Service
Table 26. Date of Enter into Orthostatic Hypotension Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 29. Global Orthostatic Hypotension Market Size Share by Type (2015-2020)
Table 30. Global Orthostatic Hypotension Revenue Market Share by Type (2021-2026)
Table 31. Global Orthostatic Hypotension Market Size Share by Application (2015-2020)
Table 32. Global Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 33. Global Orthostatic Hypotension Market Size Share by Application (2021-2026)
Table 34. North America Key Players Orthostatic Hypotension Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Orthostatic Hypotension Market Share (2019-2020)
Table 36. North America Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 37. North America Orthostatic Hypotension Market Share by Type (2015-2020)
Table 38. North America Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 39. North America Orthostatic Hypotension Market Share by Application (2015-2020)
Table 40. Europe Key Players Orthostatic Hypotension Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Orthostatic Hypotension Market Share (2019-2020)
Table 42. Europe Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Orthostatic Hypotension Market Share by Type (2015-2020)
Table 44. Europe Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Orthostatic Hypotension Market Share by Application (2015-2020)
Table 46. China Key Players Orthostatic Hypotension Revenue (2019-2020) (Million US$)
Table 47. China Key Players Orthostatic Hypotension Market Share (2019-2020)
Table 48. China Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 49. China Orthostatic Hypotension Market Share by Type (2015-2020)
Table 50. China Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 51. China Orthostatic Hypotension Market Share by Application (2015-2020)
Table 52. Japan Key Players Orthostatic Hypotension Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Orthostatic Hypotension Market Share (2019-2020)
Table 54. Japan Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Orthostatic Hypotension Market Share by Type (2015-2020)
Table 56. Japan Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Orthostatic Hypotension Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Orthostatic Hypotension Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Orthostatic Hypotension Market Share (2019-2020)
Table 60. Southeast Asia Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Orthostatic Hypotension Market Share by Type (2015-2020)
Table 62. Southeast Asia Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Orthostatic Hypotension Market Share by Application (2015-2020)
Table 64. India Key Players Orthostatic Hypotension Revenue (2019-2020) (Million US$)
Table 65. India Key Players Orthostatic Hypotension Market Share (2019-2020)
Table 66. India Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 67. India Orthostatic Hypotension Market Share by Type (2015-2020)
Table 68. India Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 69. India Orthostatic Hypotension Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Orthostatic Hypotension Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Orthostatic Hypotension Market Share (2019-2020)
Table 72. Central & South America Orthostatic Hypotension Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Orthostatic Hypotension Market Share by Type (2015-2020)
Table 74. Central & South America Orthostatic Hypotension Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Orthostatic Hypotension Market Share by Application (2015-2020)
Table 76. Mylan Company Details
Table 77. Mylan Business Overview
Table 78. Mylan Product
Table 79. Mylan Revenue in Orthostatic Hypotension Business (2015-2020) (Million US$)
Table 80. Mylan Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Orthostatic Hypotension Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Upsher-Smith Laboratories Company Details
Table 87. Upsher-Smith Laboratories Business Overview
Table 88. Upsher-Smith Laboratories Product
Table 89. Upsher-Smith Laboratories Revenue in Orthostatic Hypotension Business (2015-2020) (Million US$)
Table 90. Upsher-Smith Laboratories Recent Development
Table 91. Chelsea Therapeutics Company Details
Table 92. Chelsea Therapeutics Business Overview
Table 93. Chelsea Therapeutics Product
Table 94. Chelsea Therapeutics Revenue in Orthostatic Hypotension Business (2015-2020) (Million US$)
Table 95. Chelsea Therapeutics Recent Development
Table 96. Amgen Company Details
Table 97. Amgen Business Overview
Table 98. Amgen Product
Table 99. Amgen Revenue in Orthostatic Hypotension Business (2015-2020) (Million US$)
Table 100. Amgen Recent Development
Table 101. Apotex Company Details
Table 102. Apotex Business Overview
Table 103. Apotex Product
Table 104. Apotex Revenue in Orthostatic Hypotension Business (2015-2020) (Million US$)
Table 105. Apotex Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orthostatic Hypotension Market Share by Type: 2020 VS 2026
Figure 2. ECG Features
Figure 3. Blood Tests Features
Figure 4. Stress Test Features
Figure 5. Echocardiogram Features
Figure 6. Global Orthostatic Hypotension Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Orthostatic Hypotension Report Years Considered
Figure 11. Global Orthostatic Hypotension Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Orthostatic Hypotension Market Share by Regions: 2020 VS 2026
Figure 13. Global Orthostatic Hypotension Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Orthostatic Hypotension Market Share by Players in 2019
Figure 16. Global Top Orthostatic Hypotension Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthostatic Hypotension as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Orthostatic Hypotension Revenue in 2019
Figure 18. North America Orthostatic Hypotension Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Orthostatic Hypotension Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Orthostatic Hypotension Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Orthostatic Hypotension Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Orthostatic Hypotension Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Orthostatic Hypotension Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Orthostatic Hypotension Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
体位性頻脈症候群（POTS）治療の世界市場（～2026年） Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change from lying to standing causes an abnormally large increase in heart rate. Postural orthostatic tachycardia syndrome treatment may include avoiding factors that bring on symptoms, increasing dietary salt and water, comp…- 心肺ストレス検査システムの世界市場（～2026年） Global cardiopulmonary stress testing systems market is mainly driven by the rising demand for high value low volume products, and increasing innovations in the new product launches. The market is witnessing growing trend of introduction of wireless devices, and increasing awareness for early diagno…
- 血液ウイルス検査の世界市場（～2026年） Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells …
- 外来手術センターの世界市場（～2026年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ambulatory Surgical Centres Scope and Market Size Ambulator…
- 神経内分泌機能検査の世界市場（～2026年） Neuroendocrine function test is a diagnosis process of finding out the neuroendocrine tumor. Based on treatment type, the global neuroendocrine function test market is segmented surgery and medication. As surgery is widely used in the neuroendocrine function test market. Similarly, based on end user…